TrialDigestive diseases (Basel, Switzerland)2023

Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis: Data from the OCTAVE Program.

Marla C Dubinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.